JACC. Cardiovascular interventions最新文献

{"title":"Intravascular Ultrasound-Guided vs Angiography-Guided Drug-Coated Balloon Angioplasty in Patients With Complex Femoropopliteal Artery Disease","authors":"Seung-Jun Lee MD ,&nbsp;Tae-Hoon Kim MD ,&nbsp;Jae-Hwan Lee MD ,&nbsp;Chul-Min Ahn MD ,&nbsp;Sang-Hyup Lee MD ,&nbsp;Yong-Joon Lee MD ,&nbsp;Byeong-Keuk Kim MD ,&nbsp;Myeong-Ki Hong MD ,&nbsp;Yangsoo Jang MD ,&nbsp;Ha-Wook Park MD ,&nbsp;Ji Yong Jang MD ,&nbsp;Jae-Hyeong Park MD ,&nbsp;Su Hong Kim MD ,&nbsp;Eui Im MD ,&nbsp;Sang-ho Park MD ,&nbsp;Donghoon Choi MD ,&nbsp;Young-Guk Ko MD ,&nbsp;IVUS-DCB Investigators","doi":"10.1016/j.jcin.2024.10.052","DOIUrl":"10.1016/j.jcin.2024.10.052","url":null,"abstract":"<div><h3>Background</h3><div>Intravascular ultrasound (IVUS) guidance has been shown to yield favorable outcomes for endovascular treatment of femoropopliteal artery (FPA) disease with drug-coated balloon (DCB) angioplasty. However, the specific benefits of IVUS for treatment of complex FPA lesions remain uncertain.</div></div><div><h3>Objectives</h3><div>In this study, the authors compared the clinical impact of IVUS-guided vs angiography-guided DCB angioplasty in patients with complex or noncomplex FPA lesions.</div></div><div><h3>Methods</h3><div>This study was a prespecified, primary subgroup analysis of the randomized IVUS-DCB trial. Patients with FPA undergoing DCB angioplasty were randomized to receive the procedure under IVUS or angiography guidance. The primary endpoint was 12-month primary patency; secondary endpoints included clinically driven target lesion revascularization (CD-TLR), sustained clinical improvement, and hemodynamic improvement.</div></div><div><h3>Results</h3><div>Among the 237 patients enrolled, 158 had complex FPA (Trans-Atlantic Inter-Society Consensus II [TASC II] type C/D), and 79 had noncomplex FPA (TASC II type A/B). In complex FPA, IVUS guidance was associated with significantly higher rates of primary patency (82.1% vs 60.3%; HR for loss of primary patency: 0.34; 95% CI: 0.16-0.70; <em>P</em> = 0.002), freedom from CD-TLR (90.0% vs 76.9%; HR: 0.31; 95% CI: 0.13-0.75; <em>P</em> = 0.01), and sustained clinical and hemodynamic improvement relative to angiography guidance. There was no significant difference in primary patency (87.5% vs 88.2%; HR: 1.84; 95% CI: 0.39-8.60; <em>P</em> = 0.44) or occurrence secondary endpoints between the IVUS-guidance and angiography-guidance groups for patients with noncomplex FPA.</div></div><div><h3>Conclusions</h3><div>In endovascular treatment of FPA using DCB, IVUS guidance was significantly associated with improved 12-month clinical outcomes, particularly in patients with complex FPA lesions. (Intravascular Ultrasound-Guided Drug-Coated Balloon Angioplasty for Femoropopliteal Artery Disease [IVUS-DCB] trial; <span><span>NCT03517904</span><svg><path></path></svg></span>)</div></div>","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"18 5","pages":"Pages 558-569"},"PeriodicalIF":11.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143023453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Napkin-Ring Sign as a Metallic Artifact on MRI","authors":"Teruyoshi Uetani MD, PhD ,&nbsp;Shinji Inaba MD, PhD ,&nbsp;Rina Konishi MD ,&nbsp;Yu Hiasa MD ,&nbsp;Keisho Kurokawa MD ,&nbsp;Akira Oshita MD, PhD ,&nbsp;Hideo Kawakami MD, PhD","doi":"10.1016/j.jcin.2024.11.007","DOIUrl":"10.1016/j.jcin.2024.11.007","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"18 5","pages":"Pages 670-673"},"PeriodicalIF":11.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143023457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Discordance and Performance of the ARC-HBR and PRECISE-DAPT High Bleeding Risk Definitions After Coronary Stenting","authors":"Carl-Emil Lim MD ,&nbsp;Moa Simonsson MD, PhD ,&nbsp;Björn Pasternak MD, PhD ,&nbsp;Tomas Jernberg MD, PhD ,&nbsp;Gustaf Edgren MD, PhD ,&nbsp;Peter Ueda MD, PhD","doi":"10.1016/j.jcin.2024.10.032","DOIUrl":"10.1016/j.jcin.2024.10.032","url":null,"abstract":"<div><h3>Background</h3><div>The aim of the ARC-HBR (Academic Research Consortium for High Bleeding Risk) and PRECISE-DAPT (Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy) score definitions for high bleeding risk is to identify patients who would benefit from shorter or less intensive antiplatelet therapy after coronary stenting.</div></div><div><h3>Objectives</h3><div>The aim of this study was to assess the performance of the ARC-HBR and PRECISE-DAPT score definitions for high bleeding risk in routine clinical practice.</div></div><div><h3>Methods</h3><div>Using nationwide registers, all patients in Stockholm, Sweden, who were discharged after coronary stenting with dual antiplatelet therapy (January 1, 2013, to July 1, 2018) were included. Patients were categorized as high bleeding risk according to the 2 risk tools, and risk for bleeding (BARC [Bleeding Academic Research Consortium] types 3-5 or TIMI major or minor) and ischemic events (myocardial infarction or ischemic stroke) within 1 year after discharge was assessed.</div></div><div><h3>Results</h3><div>Of 7,562 patients, the proportions categorized as high bleeding risk were 27% (2,004 of 7,562) using the ARC-HBR definition and 38% (2,894 of 7,562) using the PRECISE-DAPT score; 22% (1,696 of 7,562) had discordant categorization of high bleeding risk comparing the 2 risk tools. Patients with vs without high bleeding risk according to the ARC-HBR definition had higher risk for BARC type 3 to 5 bleeding (1-year risk 7.1% vs 2.3%; HR: 3.21; 95% CI: 2.47-4.17) and ischemic events (7.8% vs 2.8%; HR: 2.96; 95% CI: 2.31-3.79). Patients with vs without high bleeding risk according to the PRECISE-DAPT score had higher risk for TIMI major or minor bleeding (4.4% vs 2.1%; HR: 2.17; 95% CI: 1.63-2.89) and ischemic events (6.2% vs 2.7%; HR: 2.38; 95% CI: 1.85-3.05). The PRECISE-DAPT score underestimated bleeding risk across almost all score levels (median absolute difference between observed and predicted 1-year risk 1.1%; Q1-Q3: 0.8%-1.4%).</div></div><div><h3>Conclusions</h3><div>There was substantial discordance in the categorization of high bleeding risk between the ARC-HBR definition and the PRECISE-DAPT score. Both tools identified patients at increased bleeding risk, but those patients also had increased ischemic risk. The PRECISE-DAPT score underestimated bleeding risk. Guideline-recommended high bleeding risk definitions may not be generalizable across patient populations, and refined scoring systems are needed.</div></div>","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"18 5","pages":"Pages 637-650"},"PeriodicalIF":11.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143023523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fusion Imaging With Mini–3D TEE Probe","authors":"Manuel Barreiro-Perez MD, PhD,&nbsp;Rodrigo Estevez-Loureiro MD, PhD,&nbsp;Berenice Caneiro-Queija MD,&nbsp;Jose Antonio Parada-Barcia MD,&nbsp;Julio César Echarte-Morales MD,&nbsp;Jose Antonio Baz MD, PhD,&nbsp;Andres Iñiguez-Romo MD, PhD","doi":"10.1016/j.jcin.2024.11.028","DOIUrl":"10.1016/j.jcin.2024.11.028","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"18 5","pages":"Pages 677-679"},"PeriodicalIF":11.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes and Impact of Device Iterations in Mitral Valve Transcatheter Edge-to-Edge Repair","authors":"Philipp von Stein MD ,&nbsp;Lukas Stolz MD ,&nbsp;Jean Marc Haurand MD ,&nbsp;Matthias Gröger MD ,&nbsp;Felix Rudolph MD ,&nbsp;Donika Mustafa ,&nbsp;Jannik Jobst MD ,&nbsp;Christoph Alexander Mues MD ,&nbsp;Amir Abbas Mahabadi MD ,&nbsp;Isabel A. Hörbrand MD ,&nbsp;Carl Schulz MD ,&nbsp;Atsushi Sugiura MD ,&nbsp;Tobias Ruf MD ,&nbsp;Philipp Lurz MD ,&nbsp;Muhammed Gerçek MD ,&nbsp;Patrick Horn MD ,&nbsp;Mirjam Kessler MD ,&nbsp;Tienush Rassaf MD ,&nbsp;Marcel Weber MD ,&nbsp;Tobias Kister MD ,&nbsp;Victor Mauri MD","doi":"10.1016/j.jcin.2024.11.016","DOIUrl":"10.1016/j.jcin.2024.11.016","url":null,"abstract":"<div><h3>Background</h3><div>The PASCAL P10 system for mitral valve transcatheter edge-to-edge repair has undergone iterations, including introduction of the narrower Ace implant and the Precision delivery system.</div></div><div><h3>Objectives</h3><div>This study sought to evaluate outcomes and the impact of PASCAL mitral valve transcatheter edge-to-edge repair device iterations.</div></div><div><h3>Methods</h3><div>The REPAIR (REgistry of PAscal for mltral Regurgitation) study is an investigator-initiated, multicenter registry including consecutive patients with mitral regurgitation (MR) treated from 2019 to 2024. Patients were stratified by device iteration: P10_only, P10/Ace_Gen1 (introduction of Ace), and P10/Ace_Prec (introduction of Precision). The primary endpoint was MR ≤1+ at discharge; secondary endpoints included technical success and MR durability (discharge vs 30 days, 1 year, and 2 years).</div></div><div><h3>Results</h3><div>A total of 2,165 patients (mean age 78 ± 10 years, 44% female, 85% in NYHA functional class ≥III, EuroSCORE II [European System for Cardiac Operative Risk Evaluation II] 4.9% [Q1-Q3: 3.0% to 8.1%]) were included: 660 P10_only, 945 P10/Ace_Gen1, and 560 P10/Ace_Prec. Median follow-up was 510 days (Q1-Q3: 369-874 days). Primary (47% [n = 1,019 of 2,142]) and secondary (52% [n = 1,123 of 2,142]) MR etiology did not change across device iterations (<em>P</em> = 0.547). Technical success was achieved in 97.0% (n = 2,099 of 2,165) with similar rates across device iterations (<em>P</em> = 0.290). MR ≤1+ was achieved in 72% (n = 1,397 of 2,085), improving with device iterations (P10_only: 66% [n = 422 of 638], P10/Ace_Gen1: 73% [n = 661 of 906], P10/Ace_Prec: 77% [n = 414 of 541]; <em>P</em> &lt; 0.001). MR grades of ≤1+ and ≤2+ slightly worsened at 30 days, 1 year, and 2 years, primarily in patients with primary MR, with no differences across iterations.</div></div><div><h3>Conclusions</h3><div>Device iterations of the PASCAL system resulted in increasing rates of achieving MR reduction to ≤1+ at discharge, with stable and high technical success rates. A slight deterioration of the initial result warrants further investigation.</div></div>","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"18 5","pages":"Pages 573-586"},"PeriodicalIF":11.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142914669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transcatheter Electrosurgical Closure of “Ventricularized” Left Atrial Appendage","authors":"Luai Madanat MD,&nbsp;Ahmad Jabri MD,&nbsp;Richard Bloomingdale MD,&nbsp;Jason P. Schott DO,&nbsp;Amr E. Abbas MD,&nbsp;Brian Renard MD,&nbsp;Alessandro Vivacqua MD,&nbsp;Nishaki Mehta MD,&nbsp;Ivan D. Hanson MD","doi":"10.1016/j.jcin.2024.11.013","DOIUrl":"10.1016/j.jcin.2024.11.013","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"18 5","pages":"Pages 674-676"},"PeriodicalIF":11.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143023516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intravascular Ultrasound","authors":"Sahil A. Parikh MD,&nbsp;Daniel J. Snyder MD","doi":"10.1016/j.jcin.2024.11.033","DOIUrl":"10.1016/j.jcin.2024.11.033","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"18 5","pages":"Pages 570-572"},"PeriodicalIF":11.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143023525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transseptal Mitral Annuloplasty With the AMEND System","authors":"Nir Levi MD,&nbsp;Adi Butnaru MD,&nbsp;Bruno Melica MD,&nbsp;Irakli Gogorishvili MD,&nbsp;Mikhael Metreveli MD,&nbsp;Sergio Berti MD,&nbsp;Thomas Modine MD,&nbsp;Andrew Czarnecki MD,&nbsp;Levan Kurashvili MD,&nbsp;Tamaz Shaburishvili MD,&nbsp;Shemy Carasso MD,&nbsp;David Meerkin MBBS","doi":"10.1016/j.jcin.2024.11.042","DOIUrl":"10.1016/j.jcin.2024.11.042","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"18 5","pages":"Pages 685-687"},"PeriodicalIF":11.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fasting vs No Fasting Prior to Percutaneous Cardiovascular Procedures","authors":"M. Haisum Maqsood MD, MS,&nbsp;Jacqueline E. Tamis-Holland MD,&nbsp;Mamas A. Mamas MD,&nbsp;Davide Capodanno MD, PhD,&nbsp;Deepak L. Bhatt MD, MPH, MBA,&nbsp;Sripal Bangalore MD, MHA","doi":"10.1016/j.jcin.2024.11.045","DOIUrl":"10.1016/j.jcin.2024.11.045","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"18 5","pages":"Pages 682-684"},"PeriodicalIF":11.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143592456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Full Issue PDF","authors":"","doi":"10.1016/S1936-8798(25)00642-9","DOIUrl":"10.1016/S1936-8798(25)00642-9","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"18 5","pages":"Pages I-CL"},"PeriodicalIF":11.7,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143592458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}